Medicinal Products


Name Zessly
Active Substance infliksimab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L04AB02
Medicinal product marketed in the Croatia Da
Educational materials
for patients / caregivers
Kartica s podsjetnikom za bolesnike, verzija listopad 2019


The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: